{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:53:16Z","timestamp":1781610796797,"version":"3.54.5"},"reference-count":90,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic kidney disease (CKD), defined as an estimated glomerular filtration rate (eGFR) below 60\u2005mL\/min\/1.73\u2005m2 or the presence of clinical, imaging, or histopathological features of kidney injury over a 3-month period, has been linked to several comorbidities including cardiovascular diseases, such as myocardial infarction, cerebrovascular diseases, renal artery stenosis and peripheral artery disease. A pro-inflammatory and pro-fibrotic state, together with the accumulation of uremic toxins and impaired calcium-phosphorus homeostasis leading to mineral and bone disorders, appear to constitute the underlying pathophysiology of peripheral artery disease in CKD patients. Despite such association and the deleterious effects of peripheral artery disease, the association between CKD and peripheral artery disease is generally underestimated in clinical practice, with physicians being less likely to initiate pharmacotherapy or offer interventional treatments to patients with CKD. Many therapeutic options, including lifestyle modifications, methods for cardiovascular risk reduction such as anti-platelet or lipid-lowering drugs, targeted pharmacotherapies, and endovascular or surgical interventions are available for the management of peripheral artery disease. However, the diagnostic and\/or therapeutic process in CKD patients is not as straightforward as it is in the general population, with misleading outcomes and higher treatment-related complications. Aim of this narrative review was to discuss the epidemiology, risk factors, underlying pathophysiology, and diagnostic and therapeutic approaches toward peripheral artery disease in CKD patients.<\/jats:p>","DOI":"10.1093\/joneph\/aajaf014","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:28:21Z","timestamp":1778171301000},"page":"246-258","source":"Crossref","is-referenced-by-count":0,"title":["Peripheral artery disease in chronic kidney disease: an underestimated comorbidity"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0190-2746","authenticated-orcid":false,"given":"Sidar","family":"Copur","sequence":"first","affiliation":[{"name":"Department of Medicine, Koc University School of Medicine , Istanbul ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2828-555X","authenticated-orcid":false,"given":"Lasin","family":"Ozbek","sequence":"additional","affiliation":[{"name":"Department of Medicine, Koc University School of Medicine , Istanbul ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8152-5471","authenticated-orcid":false,"given":"Carlo","family":"Basile","sequence":"additional","affiliation":[{"name":"Associazione Nefrologica Gabriella Sebastio , Martina Franca ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1297-0675","authenticated-orcid":false,"given":"Mehmet","family":"Kanbay","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, Koc University School of Medicine , Istanbul ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"2026061607064091600_aajaf014-B1","first-page":"362","article-title":"Lower extremity peripheral artery disease: diagnosis and treatment","volume":"99","author":"Firnhaber","year":"2019","journal-title":"Am Fam Physician"},{"key":"2026061607064091600_aajaf014-B2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Ankle Brachial Index Collaboration","year":"2008","journal-title":"JAMA"},{"key":"2026061607064091600_aajaf014-B3","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","article-title":"US Renal Data System 2018 Annual Data Report: epidemiology of kidney disease in the United States","volume":"73","author":"Saran","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"2026061607064091600_aajaf014-B4","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/0895-4356(92)90150-L","article-title":"The Edinburgh Claudication Questionnaire: an improved version of the WHO\/Rose Questionnaire for use in epidemiological surveys","volume":"45","author":"Leng","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"2026061607064091600_aajaf014-B5","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"2026061607064091600_aajaf014-B6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1161\/01.CIR.0000114519.75433.DD","article-title":"High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999\u20132000","volume":"109","author":"O'Hare","year":"2004","journal-title":"Circulation"},{"key":"2026061607064091600_aajaf014-B7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2005111204","article-title":"Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) study","volume":"18","author":"Wattanakit","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2026061607064091600_aajaf014-B8","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.2215\/CJN.00070109","article-title":"Chronic Renal Insufficiency Cohort (CRIC) study: baseline characteristics and associations with kidney function","volume":"4","author":"Lash","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026061607064091600_aajaf014-B9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1056\/NEJMcp1709326","article-title":"Chronic limb-threatening ischemia","volume":"379","author":"Farber","year":"2018","journal-title":"N Engl J Med"},{"key":"2026061607064091600_aajaf014-B10","doi-asserted-by":"publisher","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Gornik","year":"2024","journal-title":"Circulation"},{"key":"2026061607064091600_aajaf014-B11","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1161\/CIRCULATIONAHA.105.607390","article-title":"Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"114","author":"Rajagopalan","year":"2006","journal-title":"Circulation"},{"key":"2026061607064091600_aajaf014-B12","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.2147\/IJGM.S322417","article-title":"The impact of chronic kidney disease on peripheral artery disease and peripheral revascularization","volume":"14","author":"Serra","year":"2021","journal-title":"Int J Gen Med"},{"key":"2026061607064091600_aajaf014-B13","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S2213-8587(17)30183-3","article-title":"Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data","volume":"5","author":"Matsushita","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026061607064091600_aajaf014-B14","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1161\/01.HYP.0000159190.71253.c3","article-title":"Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients","volume":"45","author":"Pannier","year":"2005","journal-title":"Hypertension"},{"key":"2026061607064091600_aajaf014-B15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/HYPERTENSIONAHA.109.134205","article-title":"Inflammation and the osteogenic regulation of vascular calcification: a review and perspective","volume":"55","author":"Shao","year":"2010","journal-title":"Hypertension"},{"key":"2026061607064091600_aajaf014-B16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000453338","article-title":"High pulse-wave velocity defines a very high cardiovascular risk cohort of dialysis patients under age 60","volume":"45","author":"Ferreira","year":"2017","journal-title":"Am J Nephrol"},{"key":"2026061607064091600_aajaf014-B17","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1161\/01.CIR.0000033824.02722.F7","article-title":"Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?","volume":"106","author":"Cruickshank","year":"2002","journal-title":"Circulation"},{"key":"2026061607064091600_aajaf014-B18","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/HYPERTENSIONAHA.109.143024","article-title":"Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4","volume":"55","author":"Ford","year":"2010","journal-title":"Hypertension"},{"key":"2026061607064091600_aajaf014-B19","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00467-008-1046-0","article-title":"Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease","volume":"24","author":"Silverstein","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"2026061607064091600_aajaf014-B20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.atherosclerosis.2011.02.017","article-title":"Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease\u2013a cross-sectional study of predialysis, dialysis and kidney-transplantation patients","volume":"216","author":"Recio-Mayoral","year":"2011","journal-title":"Atherosclerosis"},{"key":"2026061607064091600_aajaf014-B21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.transproceed.2015.11.005","article-title":"Mortality on the kidney waiting list and after transplantation in patients with peripheral arterial disease: an analysis of the United States renal data system","volume":"48","author":"Brar","year":"2016","journal-title":"Transplant Proc"},{"key":"2026061607064091600_aajaf014-B22","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.atherosclerosis.2008.10.002","article-title":"Kynurenine, quinolinic acid\u2013the new factors linked to carotid atherosclerosis in patients with end-stage renal disease","volume":"204","author":"Pawlak","year":"2009","journal-title":"Atherosclerosis"},{"key":"2026061607064091600_aajaf014-B23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000351758","article-title":"Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease","volume":"38","author":"Moradi","year":"2013","journal-title":"Am J Nephrol"},{"key":"2026061607064091600_aajaf014-B24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.atherosclerosis.2012.07.012","article-title":"The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis","volume":"225","author":"Lin","year":"2012","journal-title":"Atherosclerosis"},{"key":"2026061607064091600_aajaf014-B25","doi-asserted-by":"publisher","first-page":"sfaf089","DOI":"10.1093\/ckj\/sfaf089","article-title":"Clinical management of peripheral arterial disease in chronic kidney disease-a comprehensive review from the European Renal Association CKD-MBD Working Group","volume":"18","author":"Huish","year":"2025","journal-title":"Clin Kidney J"},{"key":"2026061607064091600_aajaf014-B26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000343295","article-title":"Premature aging of the microcirculation in patients with advanced chronic kidney disease","volume":"2","author":"Thang","year":"2012","journal-title":"Nephron Extra"},{"key":"2026061607064091600_aajaf014-B27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41569-023-00903-0","article-title":"FGF23 and klotho at the intersection of kidney and cardiovascular disease","volume":"21","author":"Edmonston","year":"2024","journal-title":"Nat Rev Cardiol."},{"key":"2026061607064091600_aajaf014-B28","doi-asserted-by":"publisher","first-page":"15877","DOI":"10.1038\/s41598-021-95488-4","article-title":"Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease","volume":"11","author":"Donate-Correa","year":"2021","journal-title":"Sci Rep."},{"key":"2026061607064091600_aajaf014-B29","doi-asserted-by":"publisher","first-page":"H1414","DOI":"10.1152\/ajpheart.00272.2018","article-title":"FGF23 impairs peripheral microvascular function in renal failure","volume":"315","author":"Verkaik","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026061607064091600_aajaf014-B30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2013.12.015","article-title":"Fibroblast growth factor 23, the ankle-brachial index, and incident peripheral artery disease in the Cardiovascular Health Study","volume":"233","author":"Garimella","year":"2014","journal-title":"Atherosclerosis"},{"key":"2026061607064091600_aajaf014-B31","doi-asserted-by":"publisher","first-page":"8422","DOI":"10.1038\/s41598-022-12548-z","article-title":"Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease","volume":"12","author":"Mart\u00edn-N\u00fa\u00f1ez","year":"2022","journal-title":"Sci Rep."},{"key":"2026061607064091600_aajaf014-B32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/heartjnl-2013-304746","article-title":"Reduced Klotho is associated with the presence and severity of coronary artery disease","volume":"100","author":"Navarro-Gonz\u00e1lez","year":"2014","journal-title":"Heart"},{"key":"2026061607064091600_aajaf014-B33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2020.04.022","article-title":"Association of serum phosphate concentration with the incidence of intervention for peripheral artery disease in patients undergoing hemodialysis: 10-year outcomes of the Q-Cohort Study","volume":"304","author":"Shimamoto","year":"2020","journal-title":"Atherosclerosis"},{"key":"2026061607064091600_aajaf014-B34","doi-asserted-by":"publisher","first-page":"e36752","DOI":"10.7759\/cureus.36752","article-title":"Prevalence and predictors of peripheral vascular disease amongst predialysis hypertensive chronic kidney disease patients in Southern Nigeria","volume":"15","author":"Ovwasa","year":"2023","journal-title":"Cureus"},{"key":"2026061607064091600_aajaf014-B35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.atherosclerosis.2017.09.020","article-title":"Kidney function, bone-mineral metabolism markers, and future risk of peripheral artery disease","volume":"267","author":"Yang","year":"2017","journal-title":"Atherosclerosis"},{"key":"2026061607064091600_aajaf014-B36","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1001\/archinte.167.9.879","article-title":"Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community","volume":"167","author":"Dhingra","year":"2007","journal-title":"Arch Intern Med"},{"key":"2026061607064091600_aajaf014-B37","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1111\/j.1523-1755.2005.09310.x","article-title":"Subclinical peripheral arterial disease in patients with chronic kidney disease: prevalence and related risk factors","volume":"93","author":"de Vinuesa","year":"2005","journal-title":"Kidney Int Suppl"},{"key":"2026061607064091600_aajaf014-B38","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"2026061607064091600_aajaf014-B39","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1161\/CIR.0b013e31822e80c3","article-title":"2011 ACCF\/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"124","author":"Rooke","year":"2011","journal-title":"Circulation"},{"key":"2026061607064091600_aajaf014-B40","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA"},{"key":"2026061607064091600_aajaf014-B41","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1136\/bmj.39036.624306.68","article-title":"Intermittent claudication","volume":"334","author":"Simon","year":"2007","journal-title":"BMJ"},{"key":"2026061607064091600_aajaf014-B42","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1053\/j.ajkd.2012.02.340","article-title":"Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD care","volume":"60","author":"Garimella","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"2026061607064091600_aajaf014-B43","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1001\/archinte.158.12.1357","article-title":"Physical examination and chronic lower-extremity ischemia: a critical review","volume":"158","author":"McGee","year":"1998","journal-title":"Arch Intern Med"},{"key":"2026061607064091600_aajaf014-B44","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.105.570903","article-title":"Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study","volume":"113","author":"O'Hare","year":"2006","journal-title":"Circulation"},{"key":"2026061607064091600_aajaf014-B45","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1053\/ajkd.2002.34885","article-title":"The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics","volume":"40","author":"Leskinen","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2026061607064091600_aajaf014-B46","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1161\/01.CIR.0000112642.63927.54","article-title":"Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study","volume":"109","author":"Resnick","year":"2004","journal-title":"Circulation"},{"key":"2026061607064091600_aajaf014-B47","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"2026061607064091600_aajaf014-B48","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ejvs.2008.01.013","article-title":"Prevalence and risk factors of PAD among patients with elevated ABI","volume":"35","author":"Suominen","year":"2008","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026061607064091600_aajaf014-B49","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ejvs.2009.12.003","article-title":"PAD as a risk factor for mortality among patients with elevated ABI\u2013a clinical study","volume":"39","author":"Suominen","year":"2010","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026061607064091600_aajaf014-B50","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.2215\/CJN.09451209","article-title":"Detection of peripheral artery disease by duplex ultrasonography among hemodialysis patients","volume":"5","author":"Ogata","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026061607064091600_aajaf014-B51","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1001\/jama.301.4.415","article-title":"Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis","volume":"301","author":"Met","year":"2009","journal-title":"JAMA"},{"key":"2026061607064091600_aajaf014-B52","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.285.10.1338","article-title":"Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis","volume":"285","author":"Koelemay","year":"2001","journal-title":"JAMA"},{"key":"2026061607064091600_aajaf014-B53","doi-asserted-by":"publisher","first-page":"2058460115583034","DOI":"10.1177\/2058460115583034","article-title":"Contrast-induced nephropathy in patients with chronic kidney disease and peripheral arterial disease","volume":"4","author":"Kroneberger","year":"2015","journal-title":"Acta Radiol Open"},{"key":"2026061607064091600_aajaf014-B54","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/NEJMra021135","article-title":"Exercise training for claudication","volume":"347","author":"Stewart","year":"2002","journal-title":"N Engl J Med."},{"key":"2026061607064091600_aajaf014-B55","doi-asserted-by":"publisher","first-page":"F898","DOI":"10.1152\/ajprenal.00539.2018","article-title":"Effects of aerobic exercise on vascular function in nondialysis chronic kidney disease: a randomized controlled trial","volume":"316","author":"Kirkman","year":"2019","journal-title":"Am J Physiol Renal Physiol."},{"key":"2026061607064091600_aajaf014-B56","doi-asserted-by":"publisher","first-page":"F638","DOI":"10.1152\/ajprenal.00152.2023","article-title":"The effect of exercise on vascular health in chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials","volume":"325","author":"Davies","year":"2023","journal-title":"Am J Physiol Renal Physiol."},{"key":"2026061607064091600_aajaf014-B57","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.0954-6820.1987.tb00891.x","article-title":"Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality","volume":"221","author":"Jonason","year":"1987","journal-title":"Acta Med Scand"},{"key":"2026061607064091600_aajaf014-B58","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/j.jacc.2010.07.031","article-title":"Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trial","volume":"56","author":"Hennrikus","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"2026061607064091600_aajaf014-B59","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.amjcard.2012.02.061","article-title":"Risk factors for peripheral arterial disease among patients with chronic kidney disease","volume":"110","author":"Chen","year":"2012","journal-title":"Am J Cardiol."},{"key":"2026061607064091600_aajaf014-B60","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1046\/j.1523-1755.2003.00860.x","article-title":"Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 Study","volume":"63","author":"Foley","year":"2003","journal-title":"Kidney Int."},{"key":"2026061607064091600_aajaf014-B61","doi-asserted-by":"publisher","first-page":"609S","DOI":"10.1378\/chest.126.3_suppl.609S","article-title":"Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Clagett","year":"2004","journal-title":"Chest."},{"key":"2026061607064091600_aajaf014-B62","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"2026061607064091600_aajaf014-B63","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ejvs.2009.06.002","article-title":"Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies","volume":"38","author":"Momsen","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026061607064091600_aajaf014-B64","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jacc.2010.02.068","article-title":"Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial","volume":"56","author":"Jardine","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026061607064091600_aajaf014-B65","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"2026061607064091600_aajaf014-B66","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1001\/archinte.159.17.2041","article-title":"A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial","volume":"159","author":"Beebe","year":"1999","journal-title":"Arch Intern Med"},{"key":"2026061607064091600_aajaf014-B67","doi-asserted-by":"publisher","first-page":"Cd003748","DOI":"10.1002\/14651858.CD003748.pub5","article-title":"Cilostazol for intermittent claudication","volume":"6","author":"Brown","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2026061607064091600_aajaf014-B68","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1177\/1358863X19838327","article-title":"Outcomes with cilostazol after endovascular therapy of peripheral artery disease","volume":"24","author":"Megaly","year":"2019","journal-title":"Vasc Med"},{"key":"2026061607064091600_aajaf014-B69","doi-asserted-by":"publisher","first-page":"e018184","DOI":"10.1161\/JAHA.120.018184","article-title":"Efficacy and safety of adjunctive cilostazol to clopidogrel-treated diabetic patients with symptomatic lower extremity artery disease in the prevention of ischemic vascular events","volume":"10","author":"Kalantzi","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026061607064091600_aajaf014-B70","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2011.11.015","article-title":"United States Renal Data System 2011 Annual Data Report: atlas of chronic kidney disease & end-stage renal disease in the United States","volume":"59","author":"Collins","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"2026061607064091600_aajaf014-B71","doi-asserted-by":"publisher","first-page":"CD005262","DOI":"10.1002\/14651858.CD005262.pub3","article-title":"Pentoxifylline for intermittent claudication","volume":"9","author":"Salhiyyah","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2026061607064091600_aajaf014-B72","doi-asserted-by":"publisher","first-page":"CD005262","DOI":"10.1002\/14651858.CD005262.pub4","article-title":"Pentoxifylline for intermittent claudication","volume":"10","author":"Broderick","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2026061607064091600_aajaf014-B73","doi-asserted-by":"publisher","first-page":"e0275392","DOI":"10.1371\/journal.pone.0275392","article-title":"Systematic review the efficacy and safety of cilostazol, pentoxifylline, beraprost in the treatment of intermittent claudication: a network meta-analysis","volume":"17","author":"Liang","year":"2022","journal-title":"PLoS One"},{"key":"2026061607064091600_aajaf014-B74","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a \u00adsecondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"2026061607064091600_aajaf014-B75","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1093\/eurheartj\/ehy310","article-title":"Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"39","author":"Ridker","year":"2018","journal-title":"Eur Heart J"},{"key":"2026061607064091600_aajaf014-B76","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"key":"2026061607064091600_aajaf014-B77","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jjcc.2023.05.006","article-title":"Efficacy and safety of interleukin-6 inhibition with ziltivekimab in patients at high risk of atherosclerotic events in Japan (RESCUE-2): a randomized, double-blind, placebo-controlled, phase 2 trial","volume":"82","author":"Wada","year":"2023","journal-title":"J Cardiol"},{"key":"2026061607064091600_aajaf014-B78","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1038\/s41591-024-03156-7","article-title":"Author correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial","volume":"30","author":"Chertow","year":"2024","journal-title":"Nat Med"},{"key":"2026061607064091600_aajaf014-B79","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2215\/CJN.01070905","article-title":"Renal insufficiency and use of revascularization among a national cohort of men with advanced lower extremity peripheral arterial disease","volume":"1","author":"O'Hare","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026061607064091600_aajaf014-B80","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2215\/CJN.05600515","article-title":"CKD and acute and long-term outcome of patients with peripheral artery disease and critical limb ischemia","volume":"11","author":"L\u00fcders","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026061607064091600_aajaf014-B81","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1097\/01.ASN.0000061776.60146.02","article-title":"Impact of renal insufficiency on short-term morbidity and mortality after lower extremity revascularization: data from the Department of Veterans Affairs\u2019 National Surgical Quality Improvement Program","volume":"14","author":"O'Hare","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2026061607064091600_aajaf014-B82","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/01.ASN.0000105992.18297.63","article-title":"Postoperative mortality after nontraumatic lower extremity amputation in patients with renal insufficiency","volume":"15","author":"O'Hare","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2026061607064091600_aajaf014-B83","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1053\/ajkd.2001.25194","article-title":"Long-term outcomes of revascularization for peripheral vascular disease in end-stage renal disease patients","volume":"38","author":"Reddan","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"2026061607064091600_aajaf014-B84","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.jvs.2010.01.083","article-title":"Failure to achieve clinical improvement despite graft patency in patients undergoing infrainguinal lower extremity bypass for critical limb ischemia","volume":"51","author":"Simons","year":"2010","journal-title":"J Vasc Surg"},{"key":"2026061607064091600_aajaf014-B85","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1046\/j.1523-1755.1999.00668.x","article-title":"Nontraumatic lower extremity amputations in the medicare end-stage renal disease population","volume":"56","author":"Eggers","year":"1999","journal-title":"Kidney Int"},{"key":"2026061607064091600_aajaf014-B86","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1067\/mva.1990.24603","article-title":"End-stage renal disease\u2013is infrainguinal limb revascularization justified?","volume":"12","author":"Harrington","year":"1990","journal-title":"J Vasc Surg"},{"key":"2026061607064091600_aajaf014-B87","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1161\/CIR.0b013e31823eb07a","article-title":"Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and National Kidney Foundation","volume":"126","author":"Lentine","year":"2012","journal-title":"Circulation"},{"key":"2026061607064091600_aajaf014-B88","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1358863X16689830","article-title":"Peripheral arterial disease preoperatively may predict graft failure and mortality in kidney transplant recipients","volume":"22","author":"Patel","year":"2017","journal-title":"Vasc Med"},{"key":"2026061607064091600_aajaf014-B89","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1097\/TP.0b013e31827eef36","article-title":"Effect of peripheral vascular disease on kidney allograft outcomes: a study of U.S. renal data system","volume":"95","author":"Brar","year":"2013","journal-title":"Transplantation"},{"key":"2026061607064091600_aajaf014-B90","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/ctr.12720","article-title":"The survival benefit of kidney transplantation in the setting of combined peripheral arterial disease and end-stage renal failure","volume":"30","author":"Cassuto","year":"2016","journal-title":"Clin Transplant"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/2\/246\/68239504\/aajaf014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/2\/246\/68239504\/aajaf014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:13:34Z","timestamp":1781608414000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/39\/2\/246\/8671946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":90,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,5,7]]},"published-print":{"date-parts":[[2026,6,16]]}},"URL":"https:\/\/doi.org\/10.1093\/joneph\/aajaf014","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,3]]}}}